Global Market Size and Consumer Adoption of Daily Moisturizer
The global facial moisturizer market was valued at approximately $18.6 billion in 2024 and is projected to grow at a compound annual growth rate of 5.8% through 2030, according to Grand View Research. In 2024, NielsenIQ data showed that units of daily-use facial moisturizers grew 3.2% year-over-year in the U.S., with premium and clinical-grade segments outpacing mass-market brands. Revenue from dermatologist-recommended daily moisturizers reached an estimated $6.4 billion in 2024, driven by rising incidence of eczema and sensitive skin diagnoses. For broader market context, see the latest industry analysis at Forbes.
Consumer surveys from McKinsey & Company in 2024 indicate that 72% of women and 58% of men in the U.S. report using a moisturizer daily, up from 65% and 49% respectively in 2020. Sephora and Ulta Beauty reported that daily moisturizer SKUs accounted for 38% of their skincare revenue in fiscal 2024. The fastest-growing price tier was the $30 to $60 range, which captured 41% of unit sales in 2024. CeraVe, La Roche-Posay, and Neutrogena were the top three brands by dollar share in U.S. mass retail for daily moisturizers in 2024, per IRI data.
Key Ingredients, Formulation Trends, and Clinical Evidence
In 2024, the most clinically cited daily moisturizer ingredients were ceramides, hyaluronic acid, niacinamide, and squalane. A 2024 systematic review in the Journal of the American Academy of Dermatology found that formulations containing at least three of these ingredients improved stratum corneum hydration by 24% and reduced transepidermal water loss by 18% over 28 days. Neutrogena Hydro Boost and CeraVe Moisturizing Cream were among the most frequently recommended products by U.S. dermatologists in a 2024 survey by the American Academy of Dermatology.
Formulation trends in 2024 shifted toward lightweight gel-creams and barrier-repair creams with pH values between 4.5 and 5.5. L'Oréal's La Roche-Posay launched Toleriane Double Repair Face Moisturizer UV, which generated over $200 million in global revenue in 2024, according to company filings. Unilever reported that its Dove DermaSeries daily moisturizer line grew 12% in 2024, driven by clinical claims around ceramide replenishment. For regulatory context on ingredient safety, see the FDA's guidance on cosmetic labeling at FDA.gov.
Regulatory Filings, Public Company Exposure, and 2025 Outlook
Public companies with significant moisturizer daily revenue include L'Oréal, Unilever, Estée Lauder, and Beiersdorf. In fiscal 2024, L'Oréal's Active Cosmetics Division, which includes La Roche-Posay and CeraVe, reported revenue of €11.2 billion, with daily moisturizers as the largest sub-category. Estée Lauder reported a 4.3% decline in North American skincare revenue in Q4 2024, partly attributed to inventory corrections in the daily moisturizer channel, as noted in their 10-K filing with the SEC.